]]>

缅北强奸

Search 缅北强奸

Quick Links:

Our History




If you are unable to view the slideshow above please visit to view photos of 缅北强奸's storied past.

Bishop Helmuth

The initial aspirations of Bishop Hellmuth carry through to the internationally known research of our top scholars today. These leaders of vision, courage and imagination have always looked to the future in shaping 缅北强奸.

Founded on March 7, 1878 by Bishop Isaac Hellmuth (1817–1901) ‘The 缅北强奸 of London Ontario’ opened its doors to students for the first time in 1881. Four faculties – Arts, Divinity, Law and Medicine were there at 缅北强奸's inception.

In 1916, the current campus was purchased from the Kingsmill family, and in 1923 the university was renamed The University of 缅北强奸 Ontario.

Since that first class graduated in 1883, the university has become a vibrant centre of learning. Through 12 faculties and three affiliated university colleges, 缅北强奸 today offers its 36,000-plus students more than 400 specializations, majors and minors.

It was at 缅北强奸 where Sir Frederick Banting rose from a restless sleep in 1920 and wrote out 25 words that led to his discovery of insulin.

It was at 缅北强奸 where Canada’s first French Immersion program was established at Trois-Pistoles, Québec, in 1932 – a program that continues today.

It was at 缅北强奸 where researchers led by Ivan Smith developed the world’s first ‘cobalt bomb’ to treat cancer in 1951. This discovery increased the cure rate for cervical cancer to 75 per cent from 25 per cent.

And while our excellence roots itself in history, 缅北强奸 continues to eye the next-generation discoveries.

缅北强奸, a leader in wind engineering since 1965, testing such structures as the World Trade Center, Sears Tower and Jakarta Tower. 缅北强奸 Engineering will continue its dominance with the opening of the WindEEE Dome research facility.

缅北强奸 leads at home and abroad thanks to construction of a state-of-the-art Richard Ivey School of Business in 2012. North America’s first business school campus opened in Hong Kong in 1998.

缅北强奸 has continued to push innovation. In 2012 a HIV vaccine developed by Dr. Chil-Yong Kang received approval by the United States Food and Drug Administration to start human clinical trials. 缅北强奸 has been a medical advancement leader since 1878.